BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1970234)

  • 1. Oncogenes of stomach cancers.
    Terada M; Hattori Y; Yoshida T; Sakamoto H; Katoh O; Wada A; Yokota J; Sugimura T
    Basic Life Sci; 1990; 52():313-20. PubMed ID: 1970234
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular biology of the hst-1 gene.
    Sugimura T; Yoshida T; Sakamoto H; Katoh O; Hattori Y; Terada M
    Ciba Found Symp; 1990; 150():79-89; discussion 89-98. PubMed ID: 2142645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of fibroblast growth factor-related transforming gene hst-1.
    Yoshida T; Miyagawa K; Sakamoto H; Sugimura T; Terada M
    Methods Enzymol; 1991; 198():124-38. PubMed ID: 1830360
    [No Abstract]   [Full Text] [Related]  

  • 4. Biological significance of the hst-1 gene.
    Terada M; Yoshida T; Sakamoto H; Miyagawa K; Katoh O; Hattori Y; Sugimura T
    Princess Takamatsu Symp; 1989; 20():71-80. PubMed ID: 2535108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic sequence of hst, a transforming gene encoding a protein homologous to fibroblast growth factors and the int-2-encoded protein.
    Yoshida T; Miyagawa K; Odagiri H; Sakamoto H; Little PF; Terada M; Sugimura T
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7305-9. PubMed ID: 2959959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity.
    Taira M; Yoshida T; Miyagawa K; Sakamoto H; Terada M; Sugimura T
    Proc Natl Acad Sci U S A; 1987 May; 84(9):2980-4. PubMed ID: 2953031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GST pi gene is frequently coamplified with INT2 and HSTF1 proto-oncogenes in human breast cancers.
    Saint-Ruf C; Malfoy B; Scholl S; Zafrani B; Dutrillaux B
    Oncogene; 1991 Mar; 6(3):403-6. PubMed ID: 1826346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the hst-1 gene and its product.
    Yoshida T; Sakamoto H; Miyagawa K; Sugimura T; Terada M
    Ann N Y Acad Sci; 1991; 638():27-37. PubMed ID: 1785805
    [No Abstract]   [Full Text] [Related]  

  • 9. Appearance of malignant phenotype with partial loss of hormone dependency in androgen-dependent Shionogi Carcinoma 115 transfected with hst-1 gene.
    Furuya Y; Sato N; Watabe Y; Shimazaki J
    Jpn J Cancer Res; 1991 Nov; 82(11):1245-51. PubMed ID: 1836456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplified genes in cancer in upper digestive tract.
    Yoshida T; Sakamoto H; Terada M
    Semin Cancer Biol; 1993 Feb; 4(1):33-40. PubMed ID: 8095412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of human hst expression by an enhancer element residing in the third exon.
    Sasaki A; Kubo M; Hasan S; Yano Y; Kakinuma M
    Jpn J Cancer Res; 1991 Nov; 82(11):1191-5. PubMed ID: 1836454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hst-1 transforming protein: expression in silkworm cells and characterization as a novel heparin-binding growth factor.
    Miyagawa K; Sakamoto H; Yoshida T; Yamashita Y; Mitsui Y; Furusawa M; Maeda S; Takaku F; Sugimura T; Terada M
    Oncogene; 1988 Oct; 3(4):383-9. PubMed ID: 2978866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence analysis of the int-2/fgf-3 gene in aggressive human breast carcinomas.
    Meyers SL; Dudley JP
    Mol Carcinog; 1992; 6(4):243-51. PubMed ID: 1362493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of hst gene expression with metastatic phenotype in mouse mammary tumors.
    Murakami A; Tanaka H; Matsuzawa A
    Cell Growth Differ; 1990 May; 1(5):225-31. PubMed ID: 1964796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease of c-erbB-2 and c-myc RNA levels in tamoxifen-treated breast cancer.
    Le Roy X; Escot C; Brouillet JP; Theillet C; Maudelonde T; Simony-Lafontaine J; Pujol H; Rochefort H
    Oncogene; 1991 Mar; 6(3):431-7. PubMed ID: 1707153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Problems in multidisciplinary treatment from the standpoint of clinical characteristics in human cancers].
    Kikuchi K; Ueda M; Fujisaki M; Watanabe M; Tsuyuki A; Fujishiro Y; Kitajima M
    Nihon Geka Gakkai Zasshi; 1992 Sep; 93(9):948-51. PubMed ID: 1361657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classical gene amplifications in human breast cancer are not associated with distant solid metastases.
    Driouch K; Champème MH; Beuzelin M; Bièche I; Lidereau R
    Br J Cancer; 1997; 76(6):784-7. PubMed ID: 9310246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas.
    Tsuda T; Tahara E; Kajiyama G; Sakamoto H; Terada M; Sugimura T
    Cancer Res; 1989 Oct; 49(20):5505-8. PubMed ID: 2529025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological significance of gene amplification in carcinogenesis.
    Terada M; Sakamoto H; Ohmura Y; Tsuruta H; Akiyama N; Sasaki H; Katoh M; Hattori Y; Yoshida T
    Princess Takamatsu Symp; 1991; 22():371-80. PubMed ID: 1844251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming gene from human stomach cancers and a noncancerous portion of stomach mucosa.
    Sakamoto H; Mori M; Taira M; Yoshida T; Matsukawa S; Shimizu K; Sekiguchi M; Terada M; Sugimura T
    Proc Natl Acad Sci U S A; 1986 Jun; 83(11):3997-4001. PubMed ID: 3459165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.